Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adenine 1
- Administration, Oral 2
- Administration, Rectal 1
- Adolescent 2
- Adult 2
- Aged 1
- Animals 2
- Anti-HIV Agents 6
- Anti-Retroviral Agents 1
- antiretroviral agents 2
- antiretroviral drugs 1
- Article 5
- Biomarkers 1
- Cities 1
- Clinical Trial 1
- Cobicistat 2
- Cross-Sectional Studies 1
- Diagnostic Errors 1
- Double-Blind Method 1
- dried blood spot 1
- Emtricitabine 3
- Epidemiologic Methods 1
- epidemiology 1
- Female 2
- Genetic Variation 1
- HIV 2
- HIV-1 2
- HIV/AIDS 1
- HIV Antigens 1
- HIV Infections 6
- Homosexuality, Male 2
- Humans 6
- Immunoenzyme Techniques 1
- Incidence 1
- incidence 1
- Macaca 2
- malaria 1
- Male 5
- Medication Adherence 2
- mefloquine 1
- men who have sex with men 2
- Middle Aged 2
- mother-to-child transmission 1
- Pharmaceutical Preparations 2
- Point-of-Care Systems 1
- point-of-care test 1
- point-of-care testing 1
- Pre-Exposure Prophylaxis 2
- pre-exposure prophylaxis 1
- pregnancy 1
- PrEP 1
- prevention 1
- Pyrimidinones 1
- Quinolones 1
- Serologic Tests 1
- Sexual and Gender Minorities 2
- Tenofovir 4
- Time Factors 1
- United States 1
- Urethra 1
- urine 2
- Vaginal Creams, Foams, and Jellies 1
- Vietnam 1
- Young Adult 2
Personal Author
Corporate Author
Resource Type General
Keywords
- adherence 1
- Adolescent 1
- Adult 1
- Anti-HIV Agents 1
- Emtricitabine 1
- Heterocyclic Compounds, 3-Ring 1
- HIV 1
- HIV-1 diversity 1
- HIV Infections 1
- HIV Integrase Inhibitors 1
- HIV pre-exposure prophylaxis 1
- HIV prevention 1
- Homosexuality, Male 1
- Humans 1
- Integrases 1
- IQP0528 1
- Macaque 1
- Male 1
- men who have sex with men 1
- Middle Aged 1
- Pharmacokinetics 1
- preexposure prophylaxis 1
- PrEP 2
- PrEP adherence 1
- PrEP persistence 1
- prevention 1
- Pyridones 1
- Rectal gel 1
- Sexual and Gender Minorities 1
- tenofovir 1
- Vaginal gel 1
- Young Adult 1
Select all docs (Max 200)
1 -
10 of 10 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adenine (1)
- Administration, Oral (2)
- Administration, Rectal (1)
- Adolescent (2)
- Adult (2)
- Aged (1)
- Animals (2)
- Anti-HIV Agents (6)
- Anti-Retroviral Agents (1)
- antiretroviral agents (2)
- antiretroviral drugs (1)
- Article (5)
- Biomarkers (1)
- Cities (1)
- Clinical Trial (1)
- Cobicistat (2)
- Cross-Sectional Studies (1)
- Diagnostic Errors (1)
- Double-Blind Method (1)
- dried blood spot (1)
- Emtricitabine (3)
- Epidemiologic Methods (1)
- epidemiology (1)
- Female (2)
- Genetic Variation (1)
- HIV (2)
- HIV-1 (2)
- HIV/AIDS (1)
- HIV Antigens (1)
- HIV Infections (6)
- Homosexuality, Male (2)
- Humans (6)
- Immunoenzyme Techniques (1)
- Incidence (1)
- incidence (1)
- Macaca (2)
- malaria (1)
- Male (5)
- Medication Adherence (2)
- mefloquine (1)
- men who have sex with men (2)
- Middle Aged (2)
- mother-to-child transmission (1)
- Pharmaceutical Preparations (2)
- Point-of-Care Systems (1)
- point-of-care test (1)
- point-of-care testing (1)
- Pre-Exposure Prophylaxis (2)
- pre-exposure prophylaxis (1)
- pregnancy (1)
- PrEP (1)
- prevention (1)
- Pyrimidinones (1)
- Quinolones (1)
- Serologic Tests (1)
- Sexual and Gender Minorities (2)
- Tenofovir (4)
- Time Factors (1)
- United States (1)
- Urethra (1)
- urine (2)
- Vaginal Creams, Foams, and Jellies (1)
- Vietnam (1)
- Young Adult (2)
- adherence (1)
- Adolescent (1)
- Adult (1)
- Anti-HIV Agents (1)
- Emtricitabine (1)
- Heterocyclic Compounds, 3-Ring (1)
- HIV (1)
- HIV-1 diversity (1)
- HIV Infections (1)
- HIV Integrase Inhibitors (1)
- HIV pre-exposure prophylaxis (1)
- HIV prevention (1)
- Homosexuality, Male (1)
- Humans (1)
- Integrases (1)
- IQP0528 (1)
- Macaque (1)
- Male (1)
- men who have sex with men (1)
- Middle Aged (1)
- Pharmacokinetics (1)
- preexposure prophylaxis (1)
- PrEP (2)
- PrEP adherence (1)
- PrEP persistence (1)
- prevention (1)
- Pyridones (1)
- Rectal gel (1)
- Sexual and Gender Minorities (1)
- tenofovir (1)
- Vaginal gel (1)
- Young Adult (1)
- :Haaland, Richard E. ;Martin, AmyJul 17 2017 | AIDS. 31(11):1647-1650.
- :Haaland, Richard E. ;Otieno, KephasOct 17 2018 | AIDS Res Hum Retroviruses. 2018; 34(11):912-915.:Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an un...
- :Haaland, Richard E. ;Martin, Amy10 2021 | AIDS Res Hum Retroviruses. 37(10):744-747:Point-of-care (POC) tests for antiretroviral drugs (ARVs) could help improve individual adherence. This study sought to define the utility of urine, b...
- :Pereira, Lara E. ;Singletary, Tyana10 2018 | Drug Deliv Transl Res. 8(5):1180-1190:This study evaluated effects of differing gel volumes on pharmacokinetics (PK). IQB4012, a gel containing the non-nucleoside reverse transcriptase inh...
- :Haaland, Richard E. ;Martin, AmyNovember 01 2019 | J Acquir Immune Defic Syndr. 82(3):252-256:Background:Urine provides a minimally invasive specimen that may allow for development of rapid tests to detect antiretroviral drugs and provide oppor...
- :Shah, Neha S. ;Duong, Yen T.6 2017 | AIDS Res Hum Retroviruses. 33(6):546-554:Laboratory tests that can distinguish recent from long-term HIV infection are used to estimate HIV incidence in a population, but can potentially misc...
- :Chapin-Bardales, Johanna ;Haaland, Richard5 01 2023 | J Acquir Immune Defic Syndr. 93(1):34-41:Background:HIV pre-exposure prophylaxis (PrEP) persistence and adherence are critical to ending the HIV epidemic in the United States.Setting:In 2017 ...
- HIV-1 genetic diversity to estimate time of infection and infer adherence to preexposure prophylaxis:Council, Olivia D. ;Ruone, Susan12 01 2019 | AIDS. 33(15):2299-2307:Objective:To estimate time of HIV infection in participants from the Bangkok Tenofovir Study (BTS) with daily oral tenofovir disoproxil fumarate (TDF)...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.